The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index; none of the 8 sources its claims cite is checked for support yet.
The evolving clinical picture of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A look at 1310 patients over 16 years
Open accessAbstract
Introduction: Two decades of increasing understanding of etiopathogenesis and clinical phenotyping produces an impression the clinical face of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is changing. We sought to retrospectively analyze trends in CP/CPPS patients presenting to our clinic for evaluation over a 16-year period.Methods: Patients with CP/CPPS presenting to a tertiary clinic were evaluated prospectively from 1998–2014 with Chronic Prostatitis Symptom Index (CPSI) and UPOINT (urinary, psychosocial, organspecific, infection, neurogenic, and tenderness) categorization. Patients were stratified in four cohorts, based on year of presentation, and we retrospectively analyzed variations in symptom scores and patterns, UPOINT categorization, and treatment modalities amongst cohorts.Results: Mean age of the 1310 CP/CPPS patients was 44.7 years, while mean CPSI pain, urination, and total scores were 10.6, 4.8, and 23.3, respectively. The most prevalent UPOINT domain, urinary (U) (71.8%) was associated with a higher CPSI urination score (6.3), more frequent penile tip pain (37%), dysuria (48%), and more treatment with alpha-blockers (70%). Increase in UPOINT domains was associated with higher CPSI pain, quality of life (QoL), and total scores. Trends over time included increased prevalence of psychosocial (P), organ (O), and tenderness (T) domains, as well as increased use of alpha-blockers, neuromodulation, and phytotherapy as treatment modalities. There was little variation in age, CPSI scores, and pain locations over time.Conclusions: The changing clinical face of CP/CPPS reflects the increased recognition of psychosocial (P domain) and pelvic floor pain (T domain), along with the concomitant use of associated therapies. There was little variation of pain/urinary symptom patterns and QoL.
Overview
CoChat Summary
TL;DR
In a single tertiary clinic, 1310 Category III CP/CPPS patients evaluated from 1998–2014 showed stable age, CPSI symptom scores, and pain locations over time, while UPOINT phenotypes shifted toward more psychosocial, organ-specific, and tenderness domains and less infection domain. Referring-physician treatments increased for alpha-blockers, neuromodulation, and phytotherapy, with antibiotics used in 22.4% overall and no significant trend.
Key findings
- Overall cohort mean age was 44.7 years; mean CPSI pain, urination, QoL, and total scores were 10.6, 4.8, 7.9, and 23.3. Most prevalent UPOINT domain was urinary (U) at 71.8%, followed by organ-specific (O) 50.4%, tenderness (T) 49.2%, infection (I) 33.6%, neurologic (N) 30.7%, and psychosocial (P) 27.6%.
- Increased UPOINT domains were associated with higher CPSI pain (14.3), worse QoL (10.9), and higher total CPSI (31.4). The U domain was associated with higher CPSI urination (6.3), more penile tip pain (37%), more dysuria (48.2%), and more alpha-blocker treatment (70%); the P domain was associated with higher UPOINT total (3.3), antidepressants (29.1%), and gabapentinoids (10.2%).
- Over time, prevalence increased for P (p=0.0009), O (p<0.0001), and T (p<0.0001), and decreased for I (p<0.0001). Treatment increased for alpha-blockers (p<0.0001), neuromodulation (p<0.0001), and phytotherapy (p=0.0001); antibiotics ranged from 20.5%–27.2% across cohorts with no significant change (p=0.1759).
- There was little variation in age, CPSI scores, and pain locations over time; pain location was not associated with disease severity, UPOINT domain, or treatment modality.
Methods
- Retrospective analysis of a prospective clinical quality assurance database: 1349 CP patients evaluated 1998–2014 at a single tertiary outpatient clinic by a single urologist; 39 Category II bacterial prostatitis patients were excluded, leaving 1310 Category III CP/CPPS patients.
- Data collected at initial presentation included demographics, symptom duration, CPSI (pain, urinary, QoL/impact), and UPOINT; UPOINT scoring was retrospective before 2009 and prospective from 2009, and treatments recorded were those provided by referring physicians prior to or at evaluation.
- Patients were stratified into four cohorts by presentation year (1998–2001, 2002–2005, 2006–2009, 2010–2014). Continuous variables (age, CPSI) were analyzed by ANOVA; categorical variables (UPOINT, pain locations, treatments) by Chi-squared Test for Trend in Proportions; p<0.05 was significant.
Limitations
- Stated in the paper: the study is retrospective, from a single outpatient clinic, with evaluations by a single urologist; UPOINT scoring was retrospective before 2009 and prospective from 2009; treatment data reflect referring-physician interventions before/at initial evaluation; the authors note it is difficult to know whether phenotype-directed treatment made a significant difference to patient outcome.
- Evident from the design: no control/comparison group and no post-treatment outcome data are reported in this analysis; the authors also suggest that increased P and T domain prevalence likely reflects referring physicians’ recognition rather than a change in the patient population.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 6 Not checked · 45 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was little variation in age, CPSI scores and pain locations over time.”
- Also stated in: § Doiron et al Retrospective analysis of 1310 CP/CPPS patients · plain
“The age, CPSI score (and pain, urinary and impact/quality of life sub-scores) and pain locations did not appreciably change from 1998-2014.”
§ Doiron et al Retrospective analysis of 1310 CP/CPPS patients The evolving clinical picture of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A look at 1310 patients over 16 years > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Doiron et al Retrospective analysis of 1310 CP/CPPS patients · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Pain location was not associated with severity of disease, nor was it associated with UPOINT domain or treatment modality (Appendix 3).”
§ Doiron et al Retrospective analysis of 1310 CP/CPPS patients The evolving clinical picture of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A look at 1310 patients over 16 years > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was little variation of pain/urinary symptom patterns and QoL.”
- Also stated in: § CUAJ -Original Research Doiron et al Retrospective analysis of 1310 CP/CPPS patients Conclusions · plain
“there was little change in pain or urinary symptom patterns and QOL over the 16 years of assessment.”
§ Doiron et al Retrospective analysis of 1310 CP/CPPS patients The evolving clinical picture of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A look at 1310 patients over 16 years > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § CUAJ -Original Research Doiron et al Retrospective analysis of 1310 CP/CPPS patients Conclusions · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Positive reporting of the urinary domain was associated with a higher CPSI total score (25.8), higher CPSI urination score (6.3), more frequent penile tip pain (n=348, 37%), more frequent dysuria (n=454, 48.2%), and more were more commonly treated with alpha-blockers (n=659, 70%) (Appendix 1).”
§ Doiron et al Retrospective analysis of 1310 CP/CPPS patients The evolving clinical picture of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A look at 1310 patients over 16 years > Results
plainstates an associationn = 348- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Positive reporting of the urinary domain was associated with a higher CPSI total score (25.8), higher CPSI urination score (6.3), more frequent penile tip pain (n=348, 37%), more frequent dysuria (n=454, 48.2%), and more were more commonly treated with alpha-blockers (n=659, 70%) (Appendix 1).”
§ Doiron et al Retrospective analysis of 1310 CP/CPPS patients The evolving clinical picture of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A look at 1310 patients over 16 years > Results
plainstates an associationn = 941- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
34 more claims
Create a free account to see all 51 claims and every source verdict.
- Probably not a substantial claim. 11
- It may state two separate claims as one. 5
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Doiron et al Retrospective analysis of 1310 CP/CPPS patients The evolving clinical picture of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A look at 1310 patients over 16 years > Measures
“Data was examined first as an overall cohort and then over time in 4 separate cohorts ranging from 1998-2001, 2003-2005, 2006-2009, and 2010-2014.”
§ Doiron et al Retrospective analysis of 1310 CP/CPPS patients The evolving clinical picture of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A look at 1310 patients over 16 years > Figures and Tables
“1998-2001 2002-2005 2006-2009 2010-2014”
Citations
Cites
NIH Consensus Definition and Classification of Prostatitis
Krieger, J. N., Nyberg, Jr., & Nickel, J. C. (1999) · JAMA · doi:10.1001/jama.282.3.236 · Cited by 1,473
Self-citationLITWIN, M. S., McNAUGHTON-COLLINS, M., FOWLER, F. J., NICKEL, J. C., CALHOUN, E. A., PONTARI, M. A., ALEXANDER, R. B., FARRAR, J. T., & O'LEARY, M. P. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68562-x · Cited by 947
Self-citationNickel, J. C., Downey, J., Hunter, D., & Clark, J. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)66541-x · Cited by 457
Self-citationRees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG) (2015) · BJU International · doi:10.1111/bju.13101 · Cited by 371
Nickel, J. C., Nyberg, L. M., & Hennenfent, M. (1999) · Urology · doi:10.1016/s0090-4295(99)00205-8 · Cited by 293
Self-citationAnothaisintawee, T. (2011) · JAMA · doi:10.1001/jama.2010.1913 · Cited by 278
Self-citationShoskes, D. A., Nickel, J. C., Rackley, R. R., & Pontari, M. A. (2009) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2008.42 · Cited by 201
Self-citationShoskes, D. A., Nickel, J. C., Dolinga, R., & Prots, D. (2009) · Urology · doi:10.1016/j.urology.2008.09.074 · Cited by 196
Self-citationAlfuzosin and Symptoms of Chronic Prostatitis–Chronic Pelvic Pain Syndrome
Nickel, J. C., Krieger, J. N., McNaughton-Collins, M., Anderson, R. U., Pontari, M., Shoskes, D. A., Litwin, M. S., Alexander, R. B., White, P. C., Berger, R., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803240 · Cited by 188
Self-citationWagenlehner, F. M. E., Schneider, H., Ludwig, M., Schnitker, J., Brähler, E., & Weidner, W. (2009) · European Urology · doi:10.1016/j.eururo.2009.05.046 · Cited by 186
Research works printed but not linked: 1
- Nickel JC. Prostatitis. Can Urol Assoc J 2011; 5: 306-15.
Cited by
Piontek, K., Ketels, G., Albrecht, R., Schnurr, U., Dybowski, C., Brünahl, C. A., Riegel, B., & Löwe, B. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.02.010 · Cited by 45
Zhang, J., Zhang, X., Cai, Z., Ni, L., & Li, H. (2019) · American Journal of Men s Health · doi:10.1177/1557988319865380 · Cited by 44
von Gontard, A., Vrijens, D., Selai, C. E., Mosiello, G., Panicker, J. N., van Koeveringe, G. A., Apostolidis, A., & Anding, R. (2019) · Neurourology and Urodynamics · doi:10.1002/nau.24016 · Cited by 30
Post orgasmic illness syndrome: what do we know till now?
Abdessater, M., Elias, S., Mikhael, E., Alhammadi, A., & Beley, S. (2019) · Basic and Clinical Andrology · doi:10.1186/s12610-019-0093-7 · Cited by 25
Brünahl, C. A., Klotz, S., Dybowski, C., Albrecht, R., Höink, J., Fisch, M., Ketels, G., & Löwe, B. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053421 · Cited by 22
Piontek, K., Apfelbacher, C., Ketels, G., Brünahl, C. A., & Löwe, B. (2020) · Pain Medicine · doi:10.1093/pm/pnaa325 · Cited by 21
Piontek, K., Ketels, G., Klotz, S., Dybowski, C., Brünahl, C. A., & Löwe, B. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110707 · Cited by 20
Li, A. S.-W., Niekerk, L. M. V., Wong, A. L. Y., Matthewson, M. L., & Garry, M. I. (2022) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2022-0049 · Cited by 13
Savoca, M. P., Inferrera, A., Verderio, E. A. M., & Caccamo, D. (2019) · Mediators of Inflammation · doi:10.1155/2019/7894017 · Cited by 9
Ichihara, K., Takahashi, S., Hiyama, Y., Masumori, N., Nagae, H., Ito, S., Wada, K., Betsunoh, H., Hamasuna, R., Togo, Y., et al. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.01.005 · Cited by 6
Efficacy and Safety of Drug Combinations for Chronic Pelvic Pain: Protocol for a Systematic Review
Mohiuddin, M., Park, R., Wesselmann, U., Pukall, C. F., Jarvi, K. A., Nickel, C., Doiron, R. C., & Gilron, I. (2021) · JMIR Research Protocols · doi:10.2196/21909 · Cited by 5
Self-citationChronic Prostatitis/Chronic Pelvic Pain Syndrome
Doiron, R. C., & Nickel, J. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-28599-9_17 · Cited by 4
Self-citationOrigo, D., Farra, F. D., Bruni, M. F., Catalano, A., Marzagalli, L., & Bruini, I. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03448-2 · Cited by 4
Kulchavenya, E. V., Shevchenko, S. Y., & Анатольевна, Б. А. (2018) · JOURNAL of SIBERIAN MEDICAL SCIENCES · doi:10.31549/2542-1174-2018-4-13-25 · Cited by 2
Santti, R., Yatkin, E., Bernoulli, J., & Streng, T. (2022) · Veterinary Sciences · doi:10.3390/vetsci9020060 · Cited by 2
HU, H., LIANG, H., BAO, T., ZHANG, Y., CHEN, L., & Feng, X.-X. (2024) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519424400451 · Cited by 1
Overview on the clinical presentation and indications: Part B
Erasmus, L. J. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815565-3.00011-4 · Cited by 1
Pinar, U., Phé, V., & Morgan Rouprêt, A. (2022) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(22)46456-7 · Cited by 1
Chronic prostatitis: differential diagnosis. Case report discussion
Kovalyk, V. P., & Ekusheva, E. V. (2019) · Journal of clinical practice · doi:10.17816/clinpract10285-90
V Congreso Internacional Universitario Trail Running y Raids de Aventura Ruta de las Fortalezas 2019
Pato, A. S., González-Gálvez, N., García-Roca, J. A., Vaquero‐Cristóbal, R., Meroño, L., & Ortiz, B. Z. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.5281/zenodo.5498221
Красилюк, Л. І., Костєв, Ф. І., & Руденко, О. В. (2019) · Health of Man · doi:10.30841/2307-5090.2.2019.179970
Erectile Dysfunction among Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Roshdy, W. M., Farag, A. M., Ghobish, A., & El‐Sakka, A. I. (2025) · Suez Canal University Medical Journal · doi:10.21608/scumj.2025.437537
Reiter, B., Andreas, S., Schumann, L., Bender, B., Schnorr, I., Heidenreich, A., Stephan, C., Prunotto, A., Laukhuf, A., Wehrle, J., et al. (2025) · JMIR Public Health and Surveillance · doi:10.2196/81092
Talyshinskii, A., Kudakova, F., Staroseltseva, O., Gadzhiev, N. K., & Somani, B. K. (2026) · Diagnostics · doi:10.3390/diagnostics16152479
Metadata
- Authors
- Doiron, R. C., Tripp, D. A., Tolls, V., & Nickel, J. C.
- Affiliations
- Queen's University (CA)
- Venue
- Canadian Urological Association Journal
- Published
- 2018-02-19
- Volume
- 12
- Issue
- 6
- Pages
- 196-202
- ISSN
- 1911-6470 (ISSN-L)
- 1920-1214
- PMC
- PMC5994985
- OpenAlex
- W2791876036
- Cited by
- 24
- References
- 17
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2022: 5 · 2021: 4 · 2020: 2 · 2019: 8 · 2018: 1
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Canadian Urological Association Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Keywords
- chronic prostatitis/chronic pelvic pain syndrome, clinical phenotyping, Chronic Prostatitis Symptom Index, psychosocial symptoms, urinary symptoms, dysuria, alpha-blockers, neuromodulation, herbal medicine, quality of life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.